kentucky glp-1 digestive blockage class action bowel obstruction legal team Emerging Treatments for Obesity: the Role of GLP1 Receptor Agonists on Stroke GLP-1 Intolerance and Endoscopic Sleeve

As you enter perimenopause, typically in your 40s, your bodys hormones fluctuate, leading to changes in how and where your body stores fat

How to choose your GLP-1 provider Five questions, in order

Aggressive Marketing Without Adequate Safety Warnings Novo Nordisk invested roughly $11 million promoting Ozempic directly to healthcare providers while celebrities and social media influencers created a cultural phenomenon around these weight loss miracle drugs. The drug manufacturers marketed Ozempic heavily for chronic weight management despite FDA approval only for diabetes treatment

For eligible individuals, these combined effects can lead to an average weight loss of 1020% or more when paired with a healthy lifestyle

VESPER-6 : a pivotal Phase 3 study investigating once-monthly berobenatide in adults with obesity/overweight

Apr 3, 2026 You have read the articles